Princy Kumar

13.6k total citations · 1 hit paper
127 papers, 3.8k citations indexed

About

Princy Kumar is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Princy Kumar has authored 127 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Infectious Diseases, 54 papers in Virology and 39 papers in Epidemiology. Recurrent topics in Princy Kumar's work include HIV/AIDS drug development and treatment (55 papers), HIV Research and Treatment (54 papers) and HIV/AIDS Research and Interventions (42 papers). Princy Kumar is often cited by papers focused on HIV/AIDS drug development and treatment (55 papers), HIV Research and Treatment (54 papers) and HIV/AIDS Research and Interventions (42 papers). Princy Kumar collaborates with scholars based in United States, France and United Kingdom. Princy Kumar's co-authors include Elaine M. Sloand, Neal S. Young, Frank Weichold, Ann C. Collier, Timothy Flanigan, Leslie A. Kalish, Michael F. Para, Letty Mintz, Frances Wallach and Edward L. Murphy and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Princy Kumar

117 papers receiving 3.7k citations

Hit Papers

Guidelines for Improving ... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel
    2012 481 citations Melanie Thompson, Princy Kumar et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Princy Kumar 2.7k 1.7k 1.4k 751 416 127 3.8k
Jade Ghosn 3.1k 1.2× 1.9k 1.1× 1.2k 0.9× 666 0.9× 273 0.7× 177 4.7k
Marc van der Valk 2.6k 1.0× 1.9k 1.1× 1.6k 1.2× 1.3k 1.8× 295 0.7× 212 4.6k
Maria Jesús Pérez‐Elías 2.4k 0.9× 1.7k 1.0× 1.1k 0.8× 786 1.0× 167 0.4× 179 3.4k
Jeffrey L. Lennox 2.7k 1.0× 1.7k 1.0× 1.3k 1.0× 1.1k 1.4× 319 0.8× 83 4.2k
Carsten Schade Larsen 2.0k 0.8× 1.1k 0.7× 1.2k 0.9× 1.4k 1.9× 634 1.5× 176 4.0k
Brian K. Agan 2.2k 0.8× 1.7k 1.0× 1.6k 1.2× 1.1k 1.4× 485 1.2× 167 4.6k
Fujie Zhang 3.1k 1.1× 1.4k 0.8× 1.4k 1.0× 491 0.7× 162 0.4× 179 4.1k
Kholoud Porter 3.5k 1.3× 2.5k 1.5× 1.8k 1.3× 1.0k 1.3× 281 0.7× 138 4.6k
John S. Lambert 2.4k 0.9× 1.5k 0.9× 1.7k 1.3× 930 1.2× 414 1.0× 215 4.8k
Philip Keiser 1.8k 0.7× 1.3k 0.7× 1.1k 0.8× 623 0.8× 1.2k 2.9× 81 3.8k

Countries citing papers authored by Princy Kumar

Since Specialization
Citations

This map shows the geographic impact of Princy Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Princy Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Princy Kumar more than expected).

Fields of papers citing papers by Princy Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Princy Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Princy Kumar. The network helps show where Princy Kumar may publish in the future.

Co-authorship network of co-authors of Princy Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Princy Kumar. A scholar is included among the top collaborators of Princy Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Princy Kumar. Princy Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Anshika, Gaspar E. Cánepa, Mei-Ling Liou, et al.. (2024). Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control. Frontiers in Medicine. 11. 1342476–1342476. 1 indexed citations
2.
Andreatta, Kristen, Michelle L. D’Antoni, Silvia Chang, et al.. (2024). High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre‐existing HIV resistance and suboptimal adherence. Journal of Medical Virology. 96(10). e29899–e29899. 6 indexed citations
3.
Kumar, Princy, Amanda Clarke, Miguel García Deltoro, et al.. (2024). Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study. AIDS and Behavior. 29(1). 235–245.
4.
Kumar, Princy, Deborah Goldstein, Richard L. Hengel, et al.. (2023). 1581. Weight and Metabolic Changes with Long-Acting Lenacapavir in a Combination Regimen in Treatment-Naïve People with HIV-1 at Week 80. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations
5.
Barth, Shannon K., Anne K. Monroe, Michael A. Horberg, et al.. (2023). Mixed Methods Analysis of Telehealth Experience, Satisfaction, and Quality of Care During the COVID Pandemic Among Persons with HIV in Washington, DC. AIDS and Behavior. 28(3). 912–923. 2 indexed citations
6.
Jiang, Xiong, Fan Yang, John Paul Ryan, et al.. (2022). Cingulate transcranial direct current stimulation in adults with HIV. PLoS ONE. 17(6). e0269491–e0269491. 1 indexed citations
7.
Brogan, Anita J., et al.. (2021). The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States. PharmacoEconomics. 39(4). 421–432. 3 indexed citations
8.
9.
10.
Mantsios, Andrea, Miranda Murray, Tahilin Sanchez Karver, et al.. (2021). Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials. BMC Health Services Research. 21(1). 255–255. 34 indexed citations
11.
Cheng, Jie, et al.. (2021). IL-27 induces IFN/STAT1-dependent genes and enhances function of TIGIT+ HIVGag-specific T cells. iScience. 25(1). 103588–103588. 13 indexed citations
12.
Levy, Matthew E., Anne K. Monroe, Amanda D. Castel, et al.. (2020). Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC. Journal of Community Health. 46(1). 75–85. 9 indexed citations
13.
Boccara, Franck, Princy Kumar, Bruno Caramelli, et al.. (2020). EVOLOCUMAB USE IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS AND DYSLIPIDEMIA: PRIMARY RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (BEIJERINCK). Journal of the American College of Cardiology. 75(11). 1832–1832. 5 indexed citations
14.
Shattuck, Kyle F., Matthew Dawson, Monica M. Diaz, et al.. (2019). Low CD4 nadir linked to widespread cortical thinning in adults living with HIV. NeuroImage Clinical. 25. 102155–102155. 18 indexed citations
15.
16.
Squires, Kathleen, Linda‐Gail Bekker, Joseph J. Eron, et al.. (2013). Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-Week Results from the REALMRK Study. AIDS Research and Human Retroviruses. 29(6). 859–870. 16 indexed citations
17.
Timpone, Joseph, et al.. (2013). Pharmacologic Issues of Antiretroviral Agents and Immunosuppressive Regimens in HIV-infected Solid Organ Transplant Recipients. Infectious Disease Clinics of North America. 27(2). 473–486. 20 indexed citations
18.
Kumar, Princy. (2009). Predictors of response in GRACE (Gender, Race And Clinical Experience). 2 indexed citations
19.
20.
Havlir, Diane V., Michael P. Dubé, J. Allen McCutchan, et al.. (1998). Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS. Clinical Infectious Diseases. 27(6). 1369–1375. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jade Ghosn Breakdown of academic impact, for papers by Marc van der Valk Breakdown of academic impact, for papers by Maria Jesús Pérez‐Elías Breakdown of academic impact, for papers by Jeffrey L. Lennox Breakdown of academic impact, for papers by Carsten Schade Larsen Breakdown of academic impact, for papers by Brian K. Agan Breakdown of academic impact, for papers by Fujie Zhang Breakdown of academic impact, for papers by Kholoud Porter Breakdown of academic impact, for papers by John S. Lambert Breakdown of academic impact, for papers by Philip Keiser
Rankless by CCL
2026